Gergen Mark J 4
4 · Poseida Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Gergen Mark J
DirectorExecutive Chairman
Transactions
- Tax Payment
Common Stock
2025-01-02$9.60/sh−23,313$223,805→ 630,726 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 2, 2024.
- [F2]Includes 2,748 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan (the "ESPP") on January 2, 2025.